Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.

Laino AS, Betts BC, Veerapathran A, Dolgalev I, Sarnaik A, Quayle SN, Jones SS, Weber JS, Woods DM.

J Immunother Cancer. 2019 Feb 6;7(1):33. doi: 10.1186/s40425-019-0517-0.

2.

High-Parameter Single-Cell Analysis.

Chattopadhyay PK, Winters AF, Lomas WE 3rd, Laino AS, Woods DM.

Annu Rev Anal Chem (Palo Alto Calif). 2019 Jun 12;12(1):411-430. doi: 10.1146/annurev-anchem-061417-125927. Epub 2019 Jan 30.

PMID:
30699035
3.

Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma.

Yusko E, Vignali M, Wilson RK, Mardis ER, Hodi FS, Horak C, Chang H, Woods DM, Robins H, Weber J.

Cancer Immunol Res. 2019 Mar;7(3):458-465. doi: 10.1158/2326-6066.CIR-18-0226. Epub 2019 Jan 11.

PMID:
30635271
4.

Energy and Protein Intake During the Transition from Parenteral to Enteral Nutrition in Infants of Very Low Birth Weight.

Falciglia GH, Murthy K, Holl JL, Palac HL, Oumarbaeva Y, Woods DM, Robinson DT.

J Pediatr. 2018 Nov;202:38-43.e1. doi: 10.1016/j.jpeds.2018.07.010. Epub 2018 Sep 5.

5.

Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma.

Woods DM, Ramakrishnan R, Laino AS, Berglund A, Walton K, Betts BC, Weber JS.

Clin Cancer Res. 2018 Dec 15;24(24):6236-6247. doi: 10.1158/1078-0432.CCR-18-1100. Epub 2018 Aug 21.

PMID:
30131384
6.

Redesigning Transplant Organ Labeling to Prevent Patient Harm and Organ Loss.

Khorzad R, Montague E, Nannicelli AP, Woods DM, Ladner DP, Brown A, Holl JL.

Prog Transplant. 2018 Sep;28(3):271-277. doi: 10.1177/1526924818781574. Epub 2018 Jul 16.

PMID:
30012054
7.

Immediate and long-term effects of a team-based quality improvement training programme.

O'Leary KJ, Fant AL, Thurk J, Bilimoria KY, Didwania AK, Gleason KM, Groth M, Holl JL, Knoten CA, Martin GJ, O'Sullivan P, Schumacher M, Woods DM.

BMJ Qual Saf. 2019 May;28(5):366-373. doi: 10.1136/bmjqs-2018-007894. Epub 2018 May 22.

PMID:
29789407
8.

The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy.

Briere D, Sudhakar N, Woods DM, Hallin J, Engstrom LD, Aranda R, Chiang H, Sodré AL, Olson P, Weber JS, Christensen JG.

Cancer Immunol Immunother. 2018 Mar;67(3):381-392. doi: 10.1007/s00262-017-2091-y. Epub 2017 Nov 9.

PMID:
29124315
9.

Predictors of responses to immune checkpoint blockade in advanced melanoma.

Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Ternès N, Jegou S, Woods DM, Sodré AL, Hansen M, Meirow Y, Sade-Feldman M, Burra A, Kwek SS, Flament C, Messaoudene M, Duong CPM, Chen L, Kwon BS, Anderson AC, Kuchroo VK, Weide B, Aubin F, Borg C, Dalle S, Beatrix O, Ayyoub M, Balme B, Tomasic G, Di Giacomo AM, Maio M, Schadendorf D, Melero I, Dréno B, Khammari A, Dummer R, Levesque M, Koguchi Y, Fong L, Lotem M, Baniyash M, Schmidt H, Svane IM, Kroemer G, Marabelle A, Michiels S, Cavalcanti A, Smyth MJ, Weber JS, Eggermont AM, Zitvogel L.

Nat Commun. 2017 Sep 19;8(1):592. doi: 10.1038/s41467-017-00608-2.

10.

T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model.

Woods DM, Woan KV, Cheng F, Sodré AL, Wang D, Wu Y, Wang Z, Chen J, Powers J, Pinilla-Ibarz J, Yu Y, Zhang Y, Wu X, Zheng X, Weber J, Hancock WW, Seto E, Villagra A, Yu XZ, Sotomayor EM.

Blood. 2017 Jul 13;130(2):146-155. doi: 10.1182/blood-2016-08-731505. Epub 2017 May 26.

11.

Verbal Communication During Airway Management and Emergent Endotracheal Intubation: Observations of Team Behavior Among Multi-institutional Pediatric Intensive Care Unit In Situ Simulations.

Rozenfeld RA, Nannicelli AP, Brown AR, Eppich WJ, Woods DM, Lestrud SO, Noah ZL, Holl JL.

J Patient Saf. 2016 Nov 2. [Epub ahead of print]

PMID:
27811586
12.

Applying the WHO conceptual framework for the International Classification for Patient Safety to a surgical population.

McElroy LM, Woods DM, Yanes AF, Skaro AI, Daud A, Curtis T, Wymore E, Holl JL, Abecassis MM, Ladner DP.

Int J Qual Health Care. 2016 Apr;28(2):166-74. doi: 10.1093/intqhc/mzw001. Epub 2016 Jan 23.

13.

A needs assessment in patient safety education for fourth-year medical students.

Jansson PS, An-Grogan Y, Eller SG, Woods DM, Kontrick AV, Salzman DH.

Am J Med Qual. 2015 Nov-Dec;30(6):601. doi: 10.1177/1062860615606018. Epub 2015 Sep 15. No abstract available.

PMID:
26373897
14.

Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.

Still CH, Craven TE, Freedman BI, Van Buren PN, Sink KM, Killeen AA, Bates JT, Bee A, Contreras G, Oparil S, Pedley CM, Wall BM, White S, Woods DM, Rodriguez CJ, Wright JT Jr; SPRINT Study Research Group.

J Am Soc Hypertens. 2015 Sep;9(9):670-9. doi: 10.1016/j.jash.2015.06.012. Epub 2015 Aug 7.

15.

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade.

Woods DM, Sodré AL, Villagra A, Sarnaik A, Sotomayor EM, Weber J.

Cancer Immunol Res. 2015 Dec;3(12):1375-85. doi: 10.1158/2326-6066.CIR-15-0077-T. Epub 2015 Aug 21.

16.

A rater training protocol to assess team performance.

Eppich W, Nannicelli AP, Seivert NP, Sohn MW, Rozenfeld R, Woods DM, Holl JL.

J Contin Educ Health Prof. 2015 Spring;35(2):83-90. doi: 10.1002/chp.21270.

PMID:
26115107
17.

Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation.

Woan KV, Lienlaf M, Perez-Villaroel P, Lee C, Cheng F, Knox T, Woods DM, Barrios K, Powers J, Sahakian E, Wang HW, Canales J, Marante D, Smalley KSM, Bergman J, Seto E, Kozikowski A, Pinilla-Ibarz J, Sarnaik A, Celis E, Weber J, Sotomayor EM, Villagra A.

Mol Oncol. 2015 Aug;9(7):1447-1457. doi: 10.1016/j.molonc.2015.04.002. Epub 2015 Apr 24.

18.

Detection of medical errors in kidney transplantation: a pilot study comparing proactive clinician debriefings to a hospital-wide incident reporting system.

McElroy LM, Daud A, Lapin B, Ross O, Woods DM, Skaro AI, Holl JL, Ladner DP.

Surgery. 2014 Nov;156(5):1106-15. doi: 10.1016/j.surg.2014.05.013. Epub 2014 Oct 17.

19.

Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function.

Sahakian E, Powers JJ, Chen J, Deng SL, Cheng F, Distler A, Woods DM, Rock-Klotz J, Sodre AL, Youn JI, Woan KV, Villagra A, Gabrilovich D, Sotomayor EM, Pinilla-Ibarz J.

Mol Immunol. 2015 Feb;63(2):579-85. doi: 10.1016/j.molimm.2014.08.002. Epub 2014 Aug 23.

20.

Making the potential benefit of teamwork training a reality.

O'Leary KJ, Woods DM.

J Hosp Med. 2014 Mar;9(3):201-2. doi: 10.1002/jhm.2142. Epub 2014 Jan 13. No abstract available.

PMID:
24420675
21.

Educating future physicians to track health care quality: feasibility and perceived impact of a health care quality report card for medical students.

O'Neill SM, Henschen BL, Unger ED, Jansson PS, Unti K, Bortoletto P, Gleason KM, Woods DM, Evans DB.

Acad Med. 2013 Oct;88(10):1564-9. doi: 10.1097/ACM.0b013e3182a36bb5.

PMID:
23969369
22.

The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity.

Woods DM, Woan K, Cheng F, Wang H, Perez-Villarroel P, Lee C, Lienlaf M, Atadja P, Seto E, Weber J, Sotomayor EM, Villagra A.

Melanoma Res. 2013 Oct;23(5):341-8. doi: 10.1097/CMR.0b013e328364c0ed.

23.

NUTORC-a transdisciplinary health services and outcomes research team in transplantation.

Ladner DP, Alonso EM, Butt Z, Caicedo JC, Cella D, Daud A, Friedewald JJ, Gordon EJ, Hazen GB, Ho BT, Hoke KR, Holl JL, Ison MG, Kang R, Mehrotra S, Preczewski LB, Ross OA, Sharaf PH, Skaro AI, Wang E, Wolf MS, Woods DM, Abecassis MM.

Transl Behav Med. 2012 Dec;2(4):446-458.

24.

The patient centered medical home as curricular model: perceived impact of the "education-centered medical home".

Henschen BL, Garcia P, Jacobson B, Ryan ER, Woods DM, Wayne DB, Evans DB.

J Gen Intern Med. 2013 Aug;28(8):1105-9. doi: 10.1007/s11606-013-2389-1.

25.

High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.

Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, Hofstetter W, Kalhor N, Lee JJ, Franklin W, Stewart DJ, Wistuba II.

J Thorac Oncol. 2012 May;7(5):833-40. doi: 10.1097/JTO.0b013e31824de09c. Erratum in: J Thorac Oncol. 2012 Jun;7(6):1065.

26.

STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.

Sen B, Peng S, Woods DM, Wistuba I, Bell D, El-Naggar AK, Lai SY, Johnson FM.

Clin Cancer Res. 2012 Jan 1;18(1):127-39. doi: 10.1158/1078-0432.CCR-11-1889. Epub 2011 Nov 16.

27.

Pregnenolone sulphate-independent inhibition of TRPM3 channels by progesterone.

Majeed Y, Tumova S, Green BL, Seymour VA, Woods DM, Agarwal AK, Naylor J, Jiang S, Picton HM, Porter KE, O'Regan DJ, Muraki K, Fishwick CW, Beech DJ.

Cell Calcium. 2012 Jan;51(1):1-11. doi: 10.1016/j.ceca.2011.09.005. Epub 2011 Oct 14.

28.

Evaluation of the toxicity of Adonis aestivalis in sheep.

Woods LW, Puschner B, Filigenzi MS, Woods DM, George LW.

Vet Rec. 2011 Jan 15;168(2):49. doi: 10.1136/vr.c6231. Epub 2011 Jan 10.

PMID:
21257561
29.

Improving Clinical Communication and Patient Safety: Clinician-Recommended Solutions.

Woods DM, Holl JL, Angst D, Echiverri SC, Johnson D, Soglin DF, Srinivasan G, Barnathan J, Amsden L, Lamkin L, Weiss KB.

In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 3: Performance and Tools). Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Aug.

30.

Leveraging Existing Assessments of Risk Now (LEARN) Safety Analysis: A Method for Extending Patient Safety Learning.

Woods DM, Holl JL, Young J, Reynolds S, Schwalenstocker E, Wears R, Barnathan J, Amsden L.

In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 1: Assessment). Rockville (MD): Agency for Healthcare Research and Quality; 2008 Aug.

31.

Assessing Chronic Illness Care Education (ACIC-E): a tool for tracking educational re-design for improving chronic care education.

Bowen JL, Provost L, Stevens DP, Johnson JK, Woods DM, Sixta CS, Wagner EH.

J Gen Intern Med. 2010 Sep;25 Suppl 4:S593-609. doi: 10.1007/s11606-010-1385-y.

32.

Developing measures of educational change for academic health care teams implementing the chronic care model in teaching practices.

Bowen JL, Stevens DP, Sixta CS, Provost L, Johnson JK, Woods DM, Wagner EH.

J Gen Intern Med. 2010 Sep;25 Suppl 4:S586-92. doi: 10.1007/s11606-010-1358-1.

33.

Joy and challenges in improving chronic illness care: capturing daily experiences of academic primary care teams.

Johnson JK, Woods DM, Stevens DP, Bowen JL, Provost LP, Sixta CS, Wagner EH.

J Gen Intern Med. 2010 Sep;25 Suppl 4:S581-5. doi: 10.1007/s11606-010-1408-8.

34.

A multi-institutional quality improvement initiative to transform education for chronic illness care in resident continuity practices.

Stevens DP, Bowen JL, Johnson JK, Woods DM, Provost LP, Holman HR, Sixta CS, Wagner EH.

J Gen Intern Med. 2010 Sep;25 Suppl 4:S574-80. doi: 10.1007/s11606-010-1392-z.

35.

Establishment of the Yellow Starthistle Rust in California: Release, Recovery, and Spread.

Woods DM, Fisher AJ, Villegas B.

Plant Dis. 2010 Feb;94(2):174-178. doi: 10.1094/PDIS-94-2-0174.

PMID:
30754263
36.

Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.

Raso MG, Behrens C, Herynk MH, Liu S, Prudkin L, Ozburn NC, Woods DM, Tang X, Mehran RJ, Moran C, Lee JJ, Wistuba II.

Clin Cancer Res. 2009 Sep 1;15(17):5359-68. doi: 10.1158/1078-0432.CCR-09-0033. Epub 2009 Aug 25.

37.

High-alert medications in the pediatric intensive care unit.

Franke HA, Woods DM, Holl JL.

Pediatr Crit Care Med. 2009 Jan;10(1):85-90. doi: 10.1097/PCC.0b013e3181936ff8.

PMID:
19057440
38.

Puccinia jaceae var. solstitialis teliospore priming on yellow starthistle.

Fisher AJ, Aegerter BJ, Gordon TR, Smith L, Woods DM.

Phytopathology. 2009 Jan;99(1):67-72. doi: 10.1094/PHYTO-99-1-0067.

39.

Gaps in pediatric clinician communication and opportunities for improvement.

Woods DM, Holl JL, Angst DB, Echiverri SC, Johnson D, Soglin DF, Srinivasan G, Amsden LB, Barnathan J, Hason T, Lamkin L, Weiss KB.

J Healthc Qual. 2008 Sep-Oct;30(5):43-54.

PMID:
18831476
40.

Australian and New Zealand guidelines for preoperative fasting.

Woods DM, Macpherson R.

Anaesth Intensive Care. 2007 Aug;35(4):622-3. No abstract available.

41.

Evaluation of the toxicity of Adonis aestivalis in calves.

Woods LW, George LW, Anderson ML, Woods DM, Filigenzi MS, Puschner B.

J Vet Diagn Invest. 2007 Sep;19(5):581-5.

PMID:
17823409
42.

Ambulatory care adverse events and preventable adverse events leading to a hospital admission.

Woods DM, Thomas EJ, Holl JL, Weiss KB, Brennan TA.

Qual Saf Health Care. 2007 Apr;16(2):127-31.

43.

Patient safety problems in adolescent medical care.

Woods DM, Holl JL, Klein JD, Thomas EJ.

J Adolesc Health. 2006 Jan;38(1):5-12.

PMID:
16387242
44.

Anatomy of a patient safety event: a pediatric patient safety taxonomy.

Woods DM, Johnson J, Holl JL, Mehra M, Thomas EJ, Ogata ES, Lannon C.

Qual Saf Health Care. 2005 Dec;14(6):422-7.

45.

First Report of Musk Thistle Rust (Puccinia carduorum) in California and Nevada.

Woods DM, Pitcairn MJ, Luster DG, Bruckart WL.

Plant Dis. 2002 Jul;86(7):814. doi: 10.1094/PDIS.2002.86.7.814B.

PMID:
30818587
46.

Polarization of Xi - and Omega - hyperons produced from neutral beams.

Woods DM, Border PM, Ciampa DP, Guglielmo G, Heller KJ, Wallace NB, Johns KA, Gao YT, Longo MJ, Rameika R.

Phys Rev D Part Fields. 1996 Dec 1;54(11):6610-6619. No abstract available.

PMID:
10020670
47.

Precision measurement of the Omega - magnetic moment.

Wallace NB, Border PM, Ciampa DP, Guglielmo G, Heller KJ, Woods DM, Johns KA, Gao YT, Longo MJ, Rameika R.

Phys Rev Lett. 1995 May 8;74(19):3732-3735. No abstract available.

PMID:
10058283
48.

Experimental enhancement of drug uptake using short-term flow occlusion: a comparison of balloon and tourniquet techniques.

Woods DM, Wright KC, Carrasco CH, Wallace S.

AJR Am J Roentgenol. 1986 Feb;146(2):375-80.

PMID:
2934961
49.

THE NON-IDENTITY OF "PURE" AND "ISOELECTRIC" GELATINS.

Williams RJ, Friedman L, Woods DM.

Science. 1932 Feb 12;75(1937):199. No abstract available.

PMID:
17752062

Supplemental Content

Loading ...
Support Center